RECENT NEWS

Built with renowned Olympus optics, intuitive software, a powerful AI and a suite of smart features, the APX100 system combines the ease of use of an all-in-one microscope with publication-quality images to make life science research more efficient.

Thermo Fisher Scientific has introduced an all-in-one liquid chromatography-mass spectrometry (LC-MS) toxicology solution to keep pace with the ever-changing landscape of emerging and illicit drugs.

Bio-Rad Laboratories has announced the launch of the SEQuoia Express Stranded RNA Library Prep Kit, providing an easy-to-use solution for constructing robust libraries to support efficient RNA-Seq workflows for comprehensive transcriptome profiling.

Randox Quality Control has launched a new Acusera Control for the accurate and reliable testing of anti-müllerian hormone (AMH).

PerkinElmer has announced the launch of the BioQule NGS System, an automated benchtop solution for next-generation sequencing (NGS) library preparation of up to eight samples.

EKF Diagnostics has launched its new EKF Link digital connectivity solution for the secure management of point-of-care (POC) analysers and associated data on one centralised platform.

Cirdan’s key partner in Australia, Australian Clinical Labs, has improved the stability and functionality of its pathology workflows through the successful deployment of Cirdan’s Laboratory Information System (LIS), ULTRA version 4.6.

Bio-Rad Laboratories, a global leader in life science research and clinical diagnostics, has announced the launch of the CFX Duet real-time PCR system to support researchers in developing singleplex and duplex quantitative PCR (qPCR) assays.

BIOHIT HealthCare has announced the launch of its new website, which has a look and feel designed to reflect the company’s vision, mission and values, while making it easier than ever for customers and partners to find the information they need.

The British In Vitro Diagnostics Association (BIVDA) has welcomed the In Vitro Diagnostic Medical Devices Regulation (IVDR) and urges continued work to deploy the new regulatory system.

Training is a resource-intensive process that can be challenging to deliver due to an ever-increasing workload and the quick turnaround times critical for patient care. Here, Wendy Leversuch considers the value of instructional videos.

Xyall, a global innovator in molecular pathology, has attracted a Series B investment of six million Euros to accelerate commercialisation of its Tissector High Throughput and Tissector Table Top systems.

Registration is LIVE for this year’s British Society for Microbial Technology (BSMT) conference, which will take place on Tuesday 19 July 2022, at the Royal Air Force Museum, Hendon.

From cancer to birth defects to infectious disease, modern gene and bioanalysis is the key to personalised medicine.

One in eight people who were hospitalised with COVID-19 between May 2020 and March 2021 were later diagnosed with myocarditis, or heart inflammation, according to major new research into the clinical long-term effects of COVID-19.

Indica Labs, a provider of computational pathology software and services, has announced a CE-IVD mark for HALO Prostate AI, a screening tool designed to assist pathologists in identifying and grading prostate cancer in needle biopsies.

A research team at the University of Bayreuth has been taking advantage of the most popular pipette controller, INTEGRA’s PIPETBOY acu 2, for the preparation of buffers, media and samples in its cell culture workflows.

Pneumagen, a clinical-stage biotechnology company developing Neumifil, a broad-spectrum antiviral intranasal drug, has reported positive topline data from a phase 1 study designed to evaluate safety and tolerability in healthy volunteers.

There are a number of infectious diseases of humans that result in specific antigens being excreted into the urine during infection. Often these antigens are glycans/carbohydrates originating from bacterial/fungal LPS or cell wall polysaccharides.

Diagnostica Medica and Proteomedix, the Swiss cancer diagnostics company, have announced that Proclarix , a new blood test for the management of prostate cancer patients, has been introduced in the routine of the laboratory.